In the context of bladder cancer, the FOXA1 expression can be altered according to different molecular subtypes (18), with elevating in luminal molecular subtype whereas diminishing in basal molecular subtype, which is in keeping with the pattern of FOXA1 expression during urothelial differentiation. Here, FOXA1 is linked to urinary bladder carcinoma.